Gene, Cell and Tissue

Published by: Kowsar

The Effects of Serotonin Receptor Antagonists on Contraction and Relaxation Responses Induced by Electrical Stimulation in the Rat Small Intestine

Farzaneh Farajian Mashhadi 1 , 2 , Robert J. Naylor 3 and Farideh A. Javid 3 , *
Authors Information
1 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Department of Pharmacology, University of Bradford, Bradford, West Yorkshire, United Kingdom
Article information
  • Gene, Cell and Tissue: April 01, 2014, 1 (1); e18311
  • Published Online: March 8, 2014
  • Article Type: Research Article
  • Received: February 3, 2014
  • Revised: February 15, 2014
  • Accepted: February 17, 2014
  • DOI: 10.17795/gct-18311

To Cite: Farajian Mashhadi F, Naylor R J, Javid F A. The Effects of Serotonin Receptor Antagonists on Contraction and Relaxation Responses Induced by Electrical Stimulation in the Rat Small Intestine, Gene Cell Tissue. 2014 ; 1(1):e18311. doi: 10.17795/gct-18311.

Abstract
Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013; 10(8): 473-86[DOI][PubMed]
  • 2. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil. 2007; 19 Suppl 2: 25-31[DOI][PubMed]
  • 3. Farajian-Mashhadi F, Naylor RJ, Javid FA. The effect of fluoxetine on electrical field stimulation-induced responses in the isolated rat small intestine. Methods Find Exp Clin Pharmacol. 2010; 32(9): 645-55[DOI][PubMed]
  • 4. Molderings GJ. Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system. Arzneimittelforschung. 2012; 62(4): 157-66[DOI][PubMed]
  • 5. Feldberg W, Toh CC. Distribution of 5-hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tract. J Physiol. 1953; 119(2-3): 352-62[PubMed]
  • 6. Erspamer V. Pharmacology of indole-alkylamines. Pharmacol Rev. 1954; 6(4): 425-87[PubMed]
  • 7. Branchek TA, Gershon MD. Development of neural receptors for serotonin in the murine bowel. J Comp Neurol. 1987; 258(4): 597-610[DOI][PubMed]
  • 8. Kirchgessner AL, Liu MT, Raymond JR, Gershon MD. Identification of cells that express 5-hydroxytryptamine1A receptors in the nervous systems of the bowel and pancreas. J Comp Neurol. 1996; 364(3): 439-55[DOI][PubMed]
  • 9. Broad RM, McDonald TJ, Cook MA. Adenosine and 5-HT inhibit substance P release from nerve endings in myenteric ganglia by distinct mechanisms. Am J Physiol. 1993; 264(3 Pt 1)-61[PubMed]
  • 10. Pan H, Galligan JJ. 5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol. 1994; 266(2 Pt 1)-8[PubMed]
  • 11. Derkach V, Surprenant A, North RA. 5-HT3 receptors are membrane ion channels. Nature. 1989; 339(6227): 706-9[DOI][PubMed]
  • 12. Mawe GM, Branchek TA, Gershon MD. Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci U S A. 1986; 83(24): 9799-803[PubMed]
  • 13. Costall B, Naylor RJ. The pharmacology of the 5-HT4 receptor. Int Clin Psychopharmacol. 1993; 8 Suppl 2: 11-8[PubMed]
  • 14. Craig DA, Clarke DE. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther. 1990; 252(3): 1378-86[PubMed]
  • 15. Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, et al. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Eur J Pharmacol. 1994; 271(2-3): 515-23[PubMed]
  • 16. Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol. 1994; 111(1): 332-8[PubMed]
  • 17. Hirst WD, Minton JA, Bromidge SM, Moss SF, Latter AJ, Riley G, et al. Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue. Br J Pharmacol. 2000; 130(7): 1597-605[DOI][PubMed]
  • 18. Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, et al. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol. 2000; 130(3): 539-48[DOI][PubMed]
  • 19. Weber LJ. Gastrointestinal 5-hydroxytryptamine depletion by p-chlorophenylalanine. Proc West Pharmacol Soc. 1969; 12: 128-9[PubMed]
  • 20. Kilbinger H, Kruel R, Pfeuffer-Friederich I, Wessler I. The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol. 1982; 319(3): 231-8[PubMed]
  • 21. Nowak TV, Harrington B, Kalbfleisch JH. Evidence for muscarinic inhibitory neurotransmission in rodent small intestine. J Pharmacol Exp Ther. 1989; 248(2): 573-80[PubMed]
  • 22. Gershon MD. Effects of tetrodotoxin on innervated smooth muscle preparations. Br J Pharmacol Chemother. 1967; 29(3): 259-79[PubMed]
  • 23. Racke K, Reimann A, Schworer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res. 1996; 73(1-2): 83-7[PubMed]
  • 24. Satoh Y, Takeuchi T, Yamazaki Y, Okishio Y, Nishio H, Takatsuji K, et al. Mediators of nonadrenergic, noncholinergic relaxation in longitudinal muscle of the intestine of ICR mice. J Smooth Muscle Res. 1999; 35(3): 65-75[PubMed]
  • 25. D'Amato M, Curro D, Montuschi P, Ciabattoni G, Ragazzoni E, Lefebvre RA. Release of vasoactive intestinal polypeptide from the rat gastric fundus. Br J Pharmacol. 1992; 105(3): 691-5[PubMed]
  • 26. Radomirov R, Venkova K. Pharmacological characteristics of the postsynaptically mediated contractile responses of guinea-pig ileum to long-lasting electrical field stimulation. Neuropharmacology. 1988; 27(7): 729-35[PubMed]
  • 27. Ivancheva C, Pencheva N, Radomirov R. Pattern of nonadrenergic, noncholinergic responses during short- or long-lasting electrical stimulation in guinea-pig ileum. Gen Pharmacol. 1997; 29(2): 233-7[PubMed]
  • 28. Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Eur J Pharmacol. 1995; 288(2): 173-86[PubMed]
  • 29. Eglen RM, Jasper JR, Chang DJ, Martin GR. The 5-HT7 receptor: orphan found. Trends Pharmacol Sci. 1997; 18(4): 104-7[PubMed]
  • 30. Malleron JL, Comte MT, Gueremy C, Peyronel JF, Truchon A, Blanchard JC, et al. Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists. J Med Chem. 1991; 34(8): 2477-83[PubMed]
  • 31. Costa M, Furness JB. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon. Br J Pharmacol. 1979; 65(2): 237-48[PubMed]
  • 32. Engel G, Hoyer D, Kalkman HO, Wick MB. Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res. 1984; 4(1-6): 113-26[PubMed]
  • 33. Javid FA, Naylor RJ. Characterisation of 5-HT2 receptor subtypes in the Suncus murinus intestine. Eur J Pharmacol. 1999; 381(2-3): 161-9[PubMed]
  • 34. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Mol Pharmacol. 1985; 27(6): 600-11[PubMed]
  • 35. Humphrey PP, Bountra C, Clayton N, Kozlowski K. Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1999; 13 Suppl 2: 31-8[PubMed]
  • 36. Bianchi C, Beani L, Crema C. Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs. Eur J Pharmacol. 1970; 12(3): 332-41[PubMed]
  • 37. Buchheit KH, Engel G, Mutschler E, Richardson B. Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(1): 36-41[PubMed]
  • 38. Spencer NJ, Nicholas SJ, Sia TC, Staikopoulos V, Kyloh M, Beckett EA. By what mechanism does ondansetron inhibit colonic migrating motor complexes: does it require endogenous serotonin in the gut wall? Neurogastroenterol Motil. 2013; 25(8): 677-85[DOI][PubMed]
  • 39. Tan M. Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting. Expert Opin Pharmacother. 2003; 4(9): 1563-71[DOI][PubMed]
  • 40. Hedge SS, Moy TM, Perry MR, Loeb M, Eglen RM. Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther. 1994; 271(2): 741-7[PubMed]
  • 41. Budhoo MR, Harris RP, Kellum JM. The role of the 5-HT4 receptor in Cl- secretion in human jejunal mucosa. Eur J Pharmacol. 1996; 314(1-2): 109-14[PubMed]
  • 42. Kuemmerle JF, Murthy KS, Grider JR, Martin DC, Makhlouf GM. Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology. 1995; 109(6): 1791-800[PubMed]
  • 43. Yamamoto I, Kuwahara A, Fujimura M, Kadowaki M, Fujimiya M. Involvement of 5-HT3 and 5-HT4 receptors in the motor activity of isolated vascularly perfused rat duodenum. Neurogastroenterol Motil. 1999; 11(6): 457-65[PubMed]
  • 44. Gebauer A, Merger M, Kilbinger H. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(2): 137-40[PubMed]
  • 45. Irving HR, Tan YY, Tochon-Danguy N, Liu H, Chetty N, Desmond PV, et al. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life Sci. 2007; 80(13): 1198-205[DOI][PubMed]
  • 46. Tonini M, Vicini R, Cervio E, De Ponti F, De Giorgio R, Barbara G, et al. 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology. 2005; 129(5): 1557-66[DOI][PubMed]
  • 47. Carter D, Champney M, Hwang B, Eglen RM. Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur J Pharmacol. 1995; 280(3): 243-50[PubMed]
  • 48. Sia TC, Whiting M, Kyloh M, Nicholas SJ, Oliver J, Brookes SJ, et al. 5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT. Front Neurosci. 2013; 7: 136[DOI][PubMed]
  • 49. Keating DJ, Spencer NJ. Release of 5-hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes. Gastroenterology. 2010; 138(2): 659-70 670 e1-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments